Baxter International (BAX) Q4 EPS Loss Deepens And Tests Bullish Margin Recovery Narrative

Simply Wall St.05-01

Baxter International (BAX) opened 2026 coming off a tough finish to last year, with Q4 2025 revenue at US$2,974 million and a basic EPS loss of US$2.01, alongside a net loss from ongoing operations of...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2632915692?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-05-01 13:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2632915692","market":"hk","top_or_hot":-1,"title":"Baxter International (BAX) Q4 EPS Loss Deepens And Tests Bullish Margin Recovery Narrative","media":"Simply Wall St.","content":"<div>\n<p>Baxter International (BAX) opened 2026 coming off a tough finish to last year, with Q4 2025 revenue at US$2,974 million and a basic EPS loss of US$2.01, alongside a net loss from ongoing operations of...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-bax/baxter-international/news/baxter-international-bax-q4-eps-loss-deepens-and-tests-bulli\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baxter International (BAX) Q4 EPS Loss Deepens And Tests Bullish Margin Recovery Narrative</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaxter International (BAX) Q4 EPS Loss Deepens And Tests Bullish Margin Recovery Narrative\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-01 13:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-bax/baxter-international/news/baxter-international-bax-q4-eps-loss-deepens-and-tests-bulli><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Baxter International (BAX) opened 2026 coming off a tough finish to last year, with Q4 2025 revenue at US$2,974 million and a basic EPS loss of US$2.01, alongside a net loss from ongoing operations of...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-bax/baxter-international/news/baxter-international-bax-q4-eps-loss-deepens-and-tests-bulli\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0006061336.USD","symbol_name":"Blackrock US Small and MidCap Opportunities A2 USD","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bax/baxter-international/news/baxter-international-bax-q4-eps-loss-deepens-and-tests-bulli","article_id":"2632915692","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bax/baxter-international/news/baxter-international-bax-q4-eps-loss-deepens-and-tests-bulli","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2632915692","pubTimestamp":1777612159,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Baxter International (BAX) opened 2026 coming off a tough finish to last year, with Q4 2025 revenue at US$2,974 million and a basic EPS loss of US$2.01, alongside a net loss from ongoing operations of US$1,035 million. Over recent quarters, revenue moved from US$2,699 million in Q3 2024 to US$2,625 million in Q1 2025 and then to US$2,974 million in Q4 2025. EPS swung between a modest profit of US$0.24 in Q2 2025 and losses in several periods, setting up a story where top line stability...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU1267930490.SGD":"TEMPLETON GLOBAL EQUITY INCOME \"AS\" (SGD) INC A","BAX":"百特国际","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","BK4588":"碎股","LU2098885051.SGD":"JPMorgan Funds - Multi-Manager Alternatives A (acc) SGD","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","BK4585":"ETF&股票定投概念","BK4112":"金融交易所和数据","LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","BK4504":"桥水持仓","BK4082":"医疗保健设备","BLSX":"Tradr 2X Long BLSH Daily ETF","BLSG":"2倍做多BLSH ETF-Leverage Shares","LU1303367103.USD":"摩根大通多经理另类基金 A (acc)"},"translate_title":"百特国际(BAX)第四季度每股收益亏损加深并考验看涨的利润率复苏叙事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLSG":0.6,"BLSX":0.6,"BAX":1.99},"content_text":"Baxter International (BAX) opened 2026 coming off a tough finish to last year, with Q4 2025 revenue at US$2,974 million and a basic EPS loss of US$2.01, alongside a net loss from ongoing operations of US$1,035 million. Over recent quarters, revenue moved from US$2,699 million in Q3 2024 to US$2,625 million in Q1 2025 and then to US$2,974 million in Q4 2025. EPS swung between a modest profit of US$0.24 in Q2 2025 and losses in several periods, setting up a story where top line stability contrasts with pressured margins. See our full analysis for Baxter International. With the headline numbers in place, the next step is to see how this earnings run-rate lines up against the prevailing Baxter International narratives that investors follow most closely. See what the community is saying about Baxter International NYSE:BAX Earnings & Revenue History as at May 2026 AdvertisementLosses Widen Even As Revenue Holds Around US$11.2b  Over the last 12 months, Baxter generated about US$11.2b in revenue and recorded a net loss from ongoing operations of US$900 million, compared with a loss of US$326 million in the prior trailing figure given. Consensus narrative points to revenue growth of about 3.7% a year and margin improvement to 7.5%, which sits against:\n     Trailing data showing Baxter has been unprofitable for the last year, with losses growing at roughly 20.5% a year over five years. Q4 2025 net loss from ongoing operations of US$1,035 million on US$2,974 million of revenue, which illustrates how much margin repair is needed for that consensus path to play out.    Valuation Screens Cheap Versus US$21.01 DCF Fair Value  With the current share price at US$17.58 and a DCF fair value of about US$21.01, the stock is cited as trading roughly 16.3% below that model estimate. The P/S multiple of 0.8x sits well under both peer levels at 5x and the US Medical Equipment industry at 2.8x. Supporters of the bullish view argue that potential earnings growth of about 30.53% a year and bullish price targets near US$21.81 can be justified, yet:\n     The last 12 months still show a loss of US$900 million, so any bullish margin recovery case starts from a clearly loss making base. Revenue growth over the last year is around 2.9%, which is slower than the higher growth path some bullish scenarios assume, so investors need to check whether their own expectations line up with that actual pace.    Bulls argue that recent losses and the discount to DCF fair value could set up a powerful recovery story if margins improve as forecast, and the full bullish thesis spells out what has to go right for that to happen. 🐂 Baxter International Bull Case Debt Coverage Risk Sits Beside Bearish Concerns  Analysis over the last 12 months flags that Baxter’s debt is not well covered by operating cash flow, which is a key balance sheet risk alongside the continued lack of profit. Bears focus on that weak debt coverage and slower revenue assumptions of about 1.9% a year, and the data gives them some support:\n     Trailing losses increasing at about 20.5% a year and a Q4 2025 basic EPS loss of US$2.01 underline how stretched the income statement has been while the company is still servicing that debt load. The bearish narrative still assumes margins can reach 6.3% and earnings of US$752.8 million by 2029, which is a large swing from the current US$900 million loss and shows that even cautious scenarios require a substantial turnaround from the present numbers.    Skeptics point to the combination of ongoing losses and thin debt coverage as a core concern and lay out how that feeds into more cautious earnings and valuation assumptions over time. 🐻 Baxter International Bear Case Next Steps To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Baxter International on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves. With both risks and rewards on the table, how does this all sit with your own view of Baxter today, and what stands out most to you? If you want to move quickly from headline impressions to the underlying data, take a look at the 3 key rewards and 1 important warning sign See What Else Is Out There Baxter is working through sizeable losses, pressured margins and weak debt coverage, which together highlight meaningful financial risk around its current profile. If that combination feels uncomfortable, shift your focus toward companies with stronger cushions by checking out the solid balance sheet and fundamentals stocks screener (44 results) and see which businesses look sturdier on the numbers.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Baxter International might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2632915692","isCrawlerRequest":true}